Journals / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 3

The role of endothelial nitric oxide synthase gene G894T and intron 4 VNTR polymorphisms in hemodialysis patients with vascular access thrombosis

Pages
239–243
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This data will be helpful in planning further eNOS association studies in vascular access thrombosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Endothelial nitric oxide synthase (eNOS) gene is a candidate gene in cardiovascular and renal diseases.
📊
Key Findings & Data:We investigated a potential role of arteriovenous fistula (AVF) thrombosis and intron 4 and G894T polymorphisms in chronic renal failure.
💡
Conclusion & Impact:This data will be helpful in planning further eNOS association studies in vascular access thrombosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Endothelial nitric oxide synthase (eNOS) gene is a candidate gene in cardiovascular and renal diseases. Several polymorphic varia- tions have been identified in eNOS gene. We investigated a potential role of arteriovenous fistula (AVF) thrombosis and intron 4 and G894T polymorphisms in chronic renal failure. Methods: We performed a case-control observational study involving 79 with/without AVF thrombosis in chronic renal failure patients. All sub- jects were genotyped by the polymerase chain reaction (PCR) and PCR-Restriction Fragment Length Polymorphism. Genotype distribution and allele frequencies were compared between groups using the chi-square test. Results: Genotype frequencies in patients with thrombosis were not significantly different from those of patients without thrombosis for eNOS G894T polymorphism (p=0.1). eNOS gene intron 4 a allele distributions seems to be associated with thrombosis in the groups. Conclusion: This study revealed that there was an association between eNOS intron 4 polymorphism and thrombosis in chronic renal failure patients. This data will be helpful in planning further eNOS association studies in vascular access thrombosis.

🔖

Cite This Article

ŞENER, E. F., EMİROĞULLARI, Ö. N., SERHATLIOĞLU, F., ÖZKUL, Y. (2022). The role of endothelial nitric oxide synthase gene G894T and intron 4 VNTR polymorphisms in hemodialysis patients with vascular access thrombosis. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 3, 239–243. https://ajindex.com/articles/436065

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tang FY, Liu FY, Xie XW. Association of angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem 2008
  2. [CrossRef] 2. Rao M, Jaber BL, Balakrishnan VS, DialGene Consortium. Gene polymorphism association studies in dialysis: cardiovascular disease. Semin Dial 2005
  3. [CrossRef] 3. Testa A, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, Tripepi G, et al. eNOS and caveolin-1 gene polymorphisms interaction and intima-media thickness: a proof of concept study in ESRD patients. Am J Hypertens 2012
  4. [CrossRef] 4. Bessias N, Paraskevas KI, Tziviskou E, Andrikopoulos V. Vascular access in elderly patients with end-stage renal disease. Int Urol Nephrol 2008
  5. [CrossRef] 5. Brophy DF, Bukaveckas BL, Ferreira-Gonzales A, Archer KJ, Martin EJ, Gehr TWB. A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis. Hemodialysis International 2009
  6. [CrossRef] 6. Başaran O, Ataç FB, Karakayalı F, Aliosmanoğlu I, Yağmurdur MC, Özdemir FN, et al. Endothelial nitric oxide synthase gene intron 4 (VNTR) polymorphism and vascular access graft thrombosis. J Invest Surg 2007
  7. [CrossRef] 7. Girndt M, Heine GH, Ulrich C, Köhler H. Gene Polymorphism Association Studies in Dialysis: Vascular Access. Seminars in Dialysis 2007
  8. [CrossRef] 8. Colomba D, Duro G, Corrao S, Argano C, Di Chiara T, Nuzzo D, et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case- control study. Immun Ageing 2008
  9. Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res 2006
  10. Wattanapitayakul SK, Mihm MJ, Young AP Bauer JA. Therapeutic implication of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001
  11. [CrossRef] 11. Buraczynska M, Ksiazek P Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant 2004
  12. [CrossRef] 12. Bellini MH, Figueira MN, Piccoli MF, Marumo JT, Cendoroglo MS, Neto MC, et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology